SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-24-010952
Filing Date
2024-08-06
Accepted
2024-08-06 07:45:51
Documents
75
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q elev-20240630x10q.htm   iXBRL 10-Q 2299140
2 EX-10.1 elev-20240630xex10d1.htm EX-10.1 72224
3 EX-31.1 elev-20240630xex31d1.htm EX-31.1 15580
4 EX-31.2 elev-20240630xex31d2.htm EX-31.2 15552
5 EX-32 elev-20240630xex32.htm EX-32 8175
  Complete submission text file 0001558370-24-010952.txt   8632330

Data Files

Seq Description Document Type Size
6 EX-101.SCH elev-20240630.xsd EX-101.SCH 51100
7 EX-101.CAL elev-20240630_cal.xml EX-101.CAL 39794
8 EX-101.DEF elev-20240630_def.xml EX-101.DEF 216376
9 EX-101.LAB elev-20240630_lab.xml EX-101.LAB 481660
10 EX-101.PRE elev-20240630_pre.xml EX-101.PRE 375372
78 EXTRACTED XBRL INSTANCE DOCUMENT elev-20240630x10q_htm.xml XML 1450073
Mailing Address 101 FEDERAL STREET SUITE 1900 BOSTON MA 02110
Business Address 101 FEDERAL STREET SUITE 1900 BOSTON MA 02110 7163711125
Elevation Oncology, Inc. (Filer) CIK: 0001783032 (see all company filings)

IRS No.: 841771427 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40523 | Film No.: 241177141
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)